Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon therapy for Behçet's disease

E Alpsoy1, E Yilmaz, E Başaran

  • 1Department of Dermatology, Akdeniz University Medical Faculty, Antalya, Turkey.

Journal of the American Academy of Dermatology
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of molecular driver mutations in recurrence of early-stage laryngeal cancer following narrow field definitive radiotherapy.

Oral oncology reports·2026
Same author

Psychosocial outcome of COVID-19 patients requiring ventilation after ECMO versus long-term mechanical ventilation.

Frontiers in cardiovascular medicine·2026
Same author

WEIGHT LOSS AND BEYOND, ASSESSMENT OF QUALITY OF LIFE AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY USING BAROS IN PATIENTS WITH OBESITY IN TURKEY.

Acta endocrinologica (Bucharest, Romania : 2005)·2024
Same author

Predictive value of the frontal QRS-T angle for a permanent pacemaker requirement in patients undergoing transcatheter aortic valve implantation.

European review for medical and pharmacological sciences·2023
Same author

The effect of L-thyroxine treatment on ventricular dysfunction and pulmonary arterial stiffness in patients with subclinical hypothyroidism.

European review for medical and pharmacological sciences·2022
Same author

The predictive value of residual SYNTAX score and SYNTAX revascularization index for contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction.

European review for medical and pharmacological sciences·2022

Interferon treatment significantly improved symptoms in Behçet

Area of Science:

  • Immunology
  • Virology
  • Dermatology

Background:

  • Behçet's disease, a trisymptom complex, lacks established standard therapies.
  • The etiology of Behçet's disease is hypothesized to be viral or immunologic.

Purpose of the Study:

  • To evaluate the efficacy of interferon therapy in patients with Behçet's disease.
  • To assess the antiviral, immunomodulatory, antiproliferative, and antitumoral effects of interferon.

Main Methods:

  • Fourteen Behçet's disease patients received escalating doses of interferon alfa-2a (3-12 MU) subcutaneously over two months.
  • A maintenance dose of 9 MU interferon alfa-2a monthly was administered to half the cohort.
  • Patients were monitored for six months pre- and post-treatment, with all symptoms systematically recorded.

Related Experiment Videos

Main Results:

  • All patients achieved symptom remission by the conclusion of the two-month treatment phase.
  • Significant reductions in oral/genital ulcers and pustular vasculitis were observed post-treatment.

Conclusions:

  • Interferon treatment demonstrates apparent effectiveness in managing Behçet's disease symptoms.
  • Further research is warranted to establish interferon as a standard therapy for Behçet's disease.